High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1

Rapid Communications in Mass Spectrometry : RCM
H Z BuP Teitelbaum

Abstract

The inhibition potential of drugs towards five major human hepatic cytochrome P450 (CYP) isozymes (CYP2A6, 3A4, 2C9, 2D6, and 2E1) was investigated via cassette dosing of the five probe substrates (coumarin, midazolam, tolbutamide, dextromethorphan, and chlorzoxazone) in human liver microsomes using a 96-well plate format. After microsomal incubations had been terminated with formic acid, the five marker metabolites (7-hydroxycoumarin, 1'-hydroxymidazolam, 4-hydroxytolbutamide, dextrorphan, and 6-hydroxychlorzoxazone) were simultaneously quantified using direct injection/online guard cartridge extraction/tandem mass spectrometry (DI-GCE/MS/MS). Several advantages resulted from the use of a short C(18) guard cartridge (4 mm in length) for DI-GCE/MS/MS, including minimal sample preparation, fast online extraction, short analysis time (2.5 min), and minimal source contamination. In addition, this method demonstrated an inter-day accuracy range from -8.7 - 7.4% with a precision less than 8.3% for the quantification of all the marker metabolites. The inhibition assay for the five CYP isozymes was evaluated using their known selective inhibitors via individual and cassette dosing of the probe substrates. The IC(50) values measured vi...Continue Reading

References

Aug 1, 1993·Pharmacogenetics·E Jacqz-AigrainT Cresteil
Jan 1, 1997·Advances in Pharmacology·F P Guengerich
May 14, 1999·Pharmaceutical Science & Technology Today·C L Crespi
Mar 16, 2000·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·H YinD Moore
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·R E White
Dec 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·H Vanden Bossche

❮ Previous
Next ❯

Citations

Dec 6, 2011·Archives of Pharmacal Research·Dong Hee NaHye Suk Lee
Apr 29, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·N V S RamakrishnaB Sumatha
Mar 13, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·R BakhtiarF Tse
Oct 29, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·E S M LutzC M Masimirembwa
Oct 29, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Tianyi ZhangChandrani Gunaratna
Jul 5, 2013·Bioanalysis·Xianmei CaiWilson Z Shou
Apr 22, 2014·Journal of Pharmaceutical and Biomedical Analysis·Dany SpaggiariSerge Rudaz
Feb 1, 2003·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Nariyasu Mano, Junichi Goto
Jul 16, 2008·Expert Opinion on Drug Metabolism & Toxicology·María José Gómez-LechónMaría Teresa Donato
Feb 19, 2010·Expert Opinion on Drug Metabolism & Toxicology·Wilson Z Shou, Jun Zhang
Jul 1, 2008·Journal of Pharmaceutical and Biomedical Analysis·Kuresh A YoudimKenneth Saunders
Feb 3, 2007·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Xiaoyan LiDafang Zhong
Feb 3, 2007·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Danielle SmithLucinda Cohen
Apr 28, 2007·Rapid Communications in Mass Spectrometry : RCM·William L FitchLudmila Alexandrova
Dec 20, 2007·Rapid Communications in Mass Spectrometry : RCM·Agustín LahozMaria José Gómez-Lechón
Oct 17, 2007·Biomedical Chromatography : BMC·Nuggehally R Srinivas
Sep 27, 2014·Biopharmaceutics & Drug Disposition·Xinmeng ChenMin Huang
Mar 18, 2010·British Journal of Clinical Pharmacology·Janne HukkanenNeal L Benowitz
Jan 1, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Miia TurpeinenPelkeonen Olavi
Sep 4, 2015·Biomarkers in Medicine·Nuggehally R Srinivas, Ramesh Mullangi
Oct 1, 2010·Pharmaceutical Methods·Saurabh PandeyRuchi Tiwari
Oct 29, 2005·Drug Discovery Today·Walter A Korfmacher
Oct 13, 2001·Journal of Mass Spectrometry : JMS
Dec 12, 2017·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Harilal PatelPankaj Patel
Jun 20, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Richard WeaverRob J Riley
Jan 26, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jeroen KoolNico P E Vermeulen
Jul 18, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Lawrence H CohenAlfin D N Vaz
Jan 29, 2008·Journal of Combinatorial Chemistry·J Phillip KennedyCraig W Lindsley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved